Xention to Study Biomarkers for AF Network

The company will research biomarkers linked to atrial fibrillation for a pan-European consortium funded with $17 million by the EU.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.